More focus is being placed on the development of membrane bioreactors as a platform technology for the manufacturing of goods with added value, including chemicals, polymers, fuels, and pharmaceuticals. This is partly because of developments in membrane characterization, fabrication, and process development aimed at meeting the needs of the biotechnological industry, which has resulted in the use of innovative reactor designs. Membranes can facilitate the delivery of substrates, removal of products, and/or retention of biological agents due to their high specific surface area and selectivity. Despite their promising laboratory performance, these bioreactor systems have not yet been adopted by industry for the production of chemicals with added value. Therefore, a deeper comprehension of these processes is required to develop scale-up strategies for industrial implementation.
In order to improve the production of value-added products, this blog series will provide an overview of recent research that uses membrane bioreactors to reach high cell concentrations, accelerate the mass transfer rate of limiting substrates, and remove toxic materials that impede the reaction. This blog series aims to summarize what has been accomplished thus far, with a particular focus on recent developments. In addition, this blog series lays the groundwork for future industrial applications of membrane bioreactors for the production of commercial products.
Stay tuned for the next blog focused on “Membrane bioreactor configuration”. If you are looking to learn more about PHILOS membranes, you can access the following links: